GHK-Cu 50mg
High Purity Lyophilized Powder
$39.99
Out of stock
GHK-Cu 50mg
GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding peptide composed of glycyl-L-histidyl-L-lysine. It is widely studied in in vitro settings for its remarkable regenerative, anti-inflammatory, and antioxidant properties. GHK-Cu plays a vital role in tissue remodeling, collagen synthesis, and cell signaling, making it a powerful molecule in regenerative biology and cosmetic science research.
Optitide Research supplies this compound in a high-purity, research-grade lyophilized format, ideal for consistent, reproducible laboratory results.
Form: Lyophilized Powder
Sequence: Gly-His-Lys-Cu
Purity: >99%
Storage:
Lyophilized: Store at -20°C, protected from light
Reconstituted: Store at 2°C–8°C and use within 10–14 days under sterile conditions
GHK-Cu is used in research for studies involving:
Skin and tissue regeneration
Collagen and ECM remodeling
Anti-inflammatory and antioxidant pathways
Hair follicle and wound healing models
DNA repair and cellular rejuvenation
Intended Use and Disclaimer:
For laboratory and research use only. Not for human or veterinary use. This product is not intended for injection, ingestion, or clinical applications.
This product has not been evaluated by the FDA and is not intended to prevent, diagnose, treat, or cure any disease. Must be used by qualified professionals in a sterile laboratory setting.
By purchasing from Optitide Research, the buyer agrees and affirms they are a qualified researcher or institution. All sales are final. Proper handling, use, and disposal are the sole responsibility of the purchaser.
Optitide supplies research-grade peptides exclusively to qualified research professionals and institutions.
Contact
Newsletter
info@optitideresearch.com
209-624-0715
© 2026. All rights reserved.


All materials offered by Optitide Research are supplied strictly for laboratory research and development use. These products are not intended for human ingestion or clinical application. The content and claims presented on this website have not been reviewed or approved by the U.S. Food and Drug Administration (FDA). None of the statements or products provided by Optitide Research are designed to diagnose, mitigate, treat, cure, or prevent any disease.
Optitide Research operates solely as a product supplier. The company is not a compounding pharmacy or chemical compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the same Act.